2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Kiran Turaga, MD, MPH, surgical oncologist, University of Chicago Cancer Center, discusses the current surgical setting of sarcoma.
Kiran Turaga, MD, MPH, surgical oncologist, University of Chicago Cancer Center, discusses the current surgical setting of sarcoma.
Although surgical resection remains standard for patients with retroperitoneal sarcomas, Turaga says, the concept of compartmental resection is being explored once again.
Recently, adjuvant systemic chemotherapy was explored in patients with sarcomas, but the data was not strong for sarcomas as a group, says Turaga. There does seem to be benefits in some subgroups, such as leiomyosarcoma.
Additionally, the recent investigation into the use of multi-receptor TKIs, such as pazopanib (Votrient), is interesting, Turaga says.